Biodexa Pharmaceuticals
Biodexa Pharmaceuticals (formerly Midatech) is a clinical-stage biopharmaceutical company focused on oncology and rare and orphan indications.
Launch date
Employees
Market cap
$38.4m
Enterprise valuation
$31m (Public information from Apr 2023)
Share price
$0.1316 MTP
Company register number 09216368
Cardiff Wales (HQ)
Financials
Estimates*
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 1.0m | - | - | - | - |
| EBITDA | (16.7m) | (10.0m) | (10.0m) | (10.0m) | (7.0m) | (6.6m) | (8.6m) |
| % EBITDA margin | - | - | (1000 %) | - | - | - | - |
| Profit | 6.7m | (16.0m) | (15.0m) | (10.0m) | (22.0m) | - | - |
| % profit margin | - | - | (1500 %) | - | - | - | - |
| EV / revenue | - | - | 2.0x | - | - | - | - |
| EV / EBITDA | - | -1.5x | -0.2x | -0.9x | -1.3x | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | £6.3m | Early VC | |
£150k | Seed | ||
| N/A | £10.0m | Growth Equity VC | |
| N/A | N/A | IPO | |
€2.7m | Grant | ||
* | N/A | £5.0m | Private Placement VC |
* | N/A | $6.0m | Post IPO Equity |
* | N/A | $7.0m | Post IPO Equity |
* | N/A | $5.0m | Private Placement VC |
* | $17.0m | Grant | |
| Total Funding | $53.2m | ||
Related Content
Recent News about Biodexa Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Biodexa Pharmaceuticals
Edit
ACQUISITION by Biodexa Pharmaceuticals Dec 2014
ACQUISITION by Biodexa Pharmaceuticals Jun 2015